How have FTXH shares performed in 2024?

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 on January 1st, 2024. Since then, FTXH stock has increased by 0.1% and is now trading at $26.65. View the best growth stocks for 2024 here .

How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF declared a dividend on Wednesday, March 20th. Investors of record on Friday, March 22nd will be given a dividend of $0.0676 per share on Thursday, March 28th. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for FTXH .

What does FTXH invest in?

First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $19.87 million assets under management.

What stocks does First Trust Nasdaq Pharmaceuticals ETF hold?

FTXH invests in 51 holdings. Some of the stocks in their portfolio include Merck & Co., Inc. (MRK) , Pfizer (PFE) , Bristol-Myers Squibb (BMY) , AbbVie (ABBV) , Johnson & Johnson (JNJ) , Eli Lilly and Company (LLY) , Amgen (AMGN) , United Therapeutics (UTHR) , Cardinal Health (CAH) and Vertex Pharmaceuticals (VRTX) .

What is the management fee for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%.

What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD) , RAIT Financial Trust (RAS) , Cummins (CMI) , Auxly Cannabis Group (CBWTF) , Blueknight Energy Partners (BKEP) , Biocept (BIOC) , BioCorRx (BICX) , BlackRock Municipal Income Trust (BFK) , AmeriGas Partners (APU) and Aphria (APHA) .

Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders?

First Trust Nasdaq Pharmaceuticals ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Janney Montgomery Scott LLC (4.90%).

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

→ Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad)

Free FTXH Stock Alerts

$26.65

+0.19 (+0.72%)

(As of 05/3/2024 ET)

Compare

Today's Range: $26.62
▼
$26.65
50-Day Range: $25.78
▼
$28.34
52-Week Range: $23.85
▼
$28.41

Volume: 2,315 shs
Average Volume: 6,792 shs
Market Capitalization: $19.99 million

Assets Under Management: $19.87 million
Dividend Yield: 1.43%
Net Expense Ratio: 0.60%

Stock Analysis Chart Dividend Holdings Options Chain Ownership Ratings Short Interest Social Media

Get First Trust Nasdaq Pharmaceuticals ETF alerts:

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

FTXH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FTXH ETF News Headlines

August 3, 2022 | stocknews.com

3 Health Care ETFs You'll Want to Own When the Market Recovers

May 25, 2022 | nasdaq.com

Surprising Analyst 12-Month Target For FTXH

May 5, 2024 | InvestorPlace (Ad)

FREE REPORT: Four top cryptos to buy for 2024

Turn on the TV, radio, or even browse The Wall Street Journal, and you’ll see breathless reports on a new crypto rally. The headlines are hard to miss: “Bitcoin rises after rapid climb to new record”—Reuters “Bitcoin surges to new record high as mainstream money flows into crypto”—CNN “Bitcoin: what has caused the cryptocurrency’s latest revival?”—The Guardian Now the question everyone seems to be asking is a simple one: How much higher does Bitcoin go from here? But according to one crypto expert—hailed as “Bitcoin royalty” for a 2011 investment that made him a millionaire many times over—that’s the wrong question to ask.

March 25, 2022 | seekingalpha.com

First Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488

February 22, 2022 | nasdaq.com

Solid Q4 Earnings Fail to Impress Pharma ETFs

November 9, 2021 | nasdaq.com

Wave of Solid Q3 Earnings Push Pharma ETFs Higher

August 19, 2021 | msn.com

4 ETF Strategies to Follow Warren Buffett's Vision

See More Headlines

Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: First Trust
Fund Name: First Trust Nasdaq Pharmaceuticals ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:FTXH
Inception Date: 9/20/2016
Fund Manager: Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web: N/A
Phone: 14089961010

Fund Focus

Asset Class: Equity
Benchmark: Nasdaq US Smart Pharmaceuticals Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 51

Fund Statistics

Assets Under Management: $19.87 million
Average Daily Volume: $4,997.00
Discount/Premium: -0.03%

Administrator, Advisor and Custodian

Administrator: The Bank of New York Mellon Corporation
Advisor: First Trust Advisors L.P.
Custodian: The Bank of New York Mellon Corporation
Distributor: First Trust Portfolios L.P.
Transfer Agent: The Bank of New York Mellon Corporation
Trustee: N/A
Lead Market Maker: Old Mission

Options

Optionable: N/A
Short Interest: 1,000 shs

Miscellaneous

Outstanding Shares: 750,000
Beta: 0.70
Creation Unit: 50,000
Creation Fee: $500.00

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Ad Colonial Metals

The Gold Grab of the Century

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

First Trust Nasdaq Pharmaceuticals ETF Expenses

Type	FTXH	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.60%	0.56%	0.54%	0.48%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.34%	0.58%
Total Expense	0.60%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	0.00%	-0.53%	-0.55%	-0.22%	-0.57%
Net Expense	0.60%	0.60%	0.60%	0.54%	0.58%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & Exposure

Top 10 FTXH Holdings

FTXH Sector Exposure

FTXH Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

FTXH ETF - Frequently Asked Questions

How have FTXH shares performed in 2024?: First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 on January 1st, 2024. Since then, FTXH stock has increased by 0.1% and is now trading at $26.65.
View the best growth stocks for 2024 here.
How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF?: First Trust Nasdaq Pharmaceuticals ETF declared a dividend on Wednesday, March 20th. Investors of record on Friday, March 22nd will be given a dividend of $0.0676 per share on Thursday, March 28th. The ex-dividend date of this dividend is Thursday, March 21st.
Read our dividend analysis for FTXH.
What does FTXH invest in?: First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $19.87 million assets under management.
What stocks does First Trust Nasdaq Pharmaceuticals ETF hold?: FTXH invests in 51 holdings. Some of the stocks in their portfolio include Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), Amgen (AMGN), United Therapeutics (UTHR), Cardinal Health (CAH) and Vertex Pharmaceuticals (VRTX).

What is the management fee for First Trust Nasdaq Pharmaceuticals ETF?: First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%.
What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC), BioCorRx (BICX), BlackRock Municipal Income Trust (BFK), AmeriGas Partners (APU) and Aphria (APHA).
Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders?: First Trust Nasdaq Pharmaceuticals ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Janney Montgomery Scott LLC (4.90%).
How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?: Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FTXH) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial